We are live on
!
Find out more
GCM
Gladius Capital Management Portfolio holdings
AUM
$1.65B
1-Year Est. Return
25.75%
This Fund
S&P 500
This Quarter
Est. Return
+11.62%
1 Year Est. Return
+25.75%
3 Year Est. Return
+78.03%
5 Year Est. Return
+67.88%
10 Year Est. Return
+218.88%
AUM
$641M
AUM Growth
-$1.76B
(-73%)
Cap. Flow
-$1.89B
Cap. Flow
% of AUM
-295.18%
Top 10 Holdings %
Top 10 Hldgs %
49.89%
Holding
439
New
59
Increased
79
Reduced
171
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$75.3M |
| 2 |
Micron Technology
MU
|
+$4.08M |
| 3 |
ExxonMobil
XOM
|
+$3.26M |
| 4 |
Hilton Worldwide
HLT
|
+$1.03M |
| 5 |
Booz Allen Hamilton
BAH
|
+$1.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.8M |
| 2 |
Apple
AAPL
|
+$31M |
| 3 |
NVIDIA
NVDA
|
+$28.4M |
| 4 |
Amazon
AMZN
|
+$25.2M |
| 5 |
Advanced Micro Devices
AMD
|
+$17.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.72% |
| 2 | Industrials | 1.16% |
| 3 | Healthcare | 1.1% |
| 4 | Consumer Discretionary | 0.85% |
| 5 | Energy | 0.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Erie Indemnity
ERIE
$12.4B
| $99.1K | 0.02% |
296
+9
| +3% | +$2.7K |
|
152
PUT
Pfizer
PFE
$146B
| $97.9K | 0.02% |
3,400
-171,600
| -98% | -$5.19M |
|
153
OneSpan
OSPN
$601M
| $94.9K | 0.01% |
+8,855
| New | +$87K |
|
154
Grand Canyon Education
LOPE
$3.91B
| $93.2K | 0.01% |
706
-754
| -52% | -$98.1K |
|
155
Acuity Brands
AYI
$10.3B
| $84.4K | 0.01% |
412
-4
| -1% | -$722 |
|
156
Franklin Covey
FC
$245M
| $79K | 0.01% |
1,815
-1,832
| -50% | -$72.6K |
|
157
Graham Holdings Company
GHC
$5.1B
| $78.7K | 0.01% |
113
-111
| -50% | -$69.1K |
|
|
HSII
158
DELISTED
Heidrick & Struggles
HSII
| $78.5K | 0.01% |
2,660
-3,412
| -56% | -$90.6K |
|
159
MSC Industrial Direct
MSM
$7.06B
| $76.6K | 0.01% |
756
+4
| +0.5% | +$396 |
|
160
Stoneridge
SRI
$213M
| $75.6K | 0.01% |
+3,864
| New | +$67.1K |
|
161
Acco Brands
ACCO
$408M
| $72.9K | 0.01% |
+11,984
| New | +$63.5K |
|
|
ONTF
162
DELISTED
ON24
ONTF
| $70.7K | 0.01% |
+8,977
| New | +$62.3K |
|
|
BECN
163
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $68K | 0.01% |
782
-61
| -7% | -$4.78K |
|
164
Biglari Holdings Class B
BH
$1.23B
| $66.3K | 0.01% |
402
+226
| +128% | +$34.9K |
|
|
MDRX
165
DELISTED
Veradigm Inc. Common Stock
MDRX
| $65.5K | 0.01% |
6,245
+3,587
| +135% | +$44K |
|
166
Resources Connection
RGP
$157M
| $64.9K | 0.01% |
+4,578
| New | +$64K |
|
|
TBI
167
Trueblue
TBI
$230M
| $64.7K | 0.01% |
4,216
-4,518
| -52% | -$63.1K |
|
168
Nature's Sunshine
NATR
$363M
| $63.4K | 0.01% |
3,666
+504
| +16% | +$8.71K |
|
169
Papa John's
PZZA
$1.01B
| $61.4K | 0.01% |
806
-811
| -50% | -$55.2K |
|
170
Cibus
CBUS
$148M
| $56.2K | 0.01% |
+2,861
| New | +$42.4K |
|
|
AVNS
171
DELISTED
Avanos Medical
AVNS
| $54.2K | 0.01% |
2,416
+934
| +63% | +$19.3K |
|
172
NRC Health Common Stock
NRC
$435M
| $52.5K | 0.01% |
1,326
+496
| +60% | +$20.8K |
|
173
Silicon Laboratories
SLAB
$7.2B
| $49.3K | 0.01% |
373
+286
| +329% | +$31.3K |
|
174
Huntsman Corp
HUN
$1.8B
| $49K | 0.01% |
1,949
-432
| -18% | -$10.5K |
|
175
Amneal Pharmaceuticals
AMRX
$5.87B
| $48.5K | 0.01% |
7,993
-1,233
| -13% | -$5.49K |
|
Similar funds
ACM
CCM
BFPW
PP
RIA
GACM
GA
Gladius Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Gladius Capital Management held 439 positions worth $641M, down 73% from $2.4B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Gladius Capital Management withdrew a net $1.89B in Q4 2023, closing 128 positions and reducing 171 holdings. Its most notable exit was Microsoft, an estimated $50.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 5.8% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Gladius Capital Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $80.3M.
- Gladius Capital Management's largest Q4 2023 buy was State Street SPDR S&P 500 ETF Trust: 168,944 shares worth $80.3M.
- Gladius Capital Management added most to Cardinal Health in Q4 2023, an estimated $679K increase.
- Gladius Capital Management's biggest Q4 2023 reduction was Advanced Micro Devices, cutting an estimated $17.8M.
- Gladius Capital Management fully exited Microsoft in Q4 2023, selling an estimated $50.8M.
- Gladius Capital Management's ten largest holdings make up 50% of its $641M portfolio in Q4 2023.
- Gladius Capital Management opened 59 new positions and closed 128 in Q4 2023.
- Gladius Capital Management's portfolio value fell 73% quarter-over-quarter to $641M.
Based on Gladius Capital Management's 13F filing for Q4 2023, filed 7 Feb 2024.